"This recognizes and rewards the spirit and productivity of our collaboration with Best Practices submission partner, Cogenics..." stated Bob Stanley, CEO/President of IO Informatics. "The [awards] are an excellent platform for companies to present and showcase their latest practical advances and successes. It also serves to allow for the exchange of information and ideas within the scientific research community, therefore fostering improvements based on open peer-review."
"We are gratified by the recognition [the awards program] has again given our CTSD product," said Phase Forward Lincoln Safety Group President Chan Russell. "We congratulate our co-recipient GSK for their innovative use of CTSD."
"We're very proud…" offered Nick Lynch, AstraZeneca Discovery, "and I think this is a marvelous opportunity to reward all the people who contributed to IBIS, [and] equally to share this with a wider audience and hopefully learn from them as well."
|